CT
HAE icon

Clearstead Trust’s Haemonetics HAE Stock Holding History

Clearstead Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5K Hold
100
– – ﹤0.01% 690
2026
Q1 		$5.64K Hold
100
– – ﹤0.01% 726
2025
Q4 		$8.02K Hold
100
– – ﹤0.01% 653
2025
Q3 		$4.87K Hold
100
– – ﹤0.01% 771
2025
Q2 		$7.46K Hold
100
– – ﹤0.01% 658
2025
Q1 		$6.36K Hold
100
– – ﹤0.01% 549
2024
Q4 		$7.81K Hold
100
– – ﹤0.01% 372
2024
Q3 		$8.04K Hold
100
– – ﹤0.01% 358
2024
Q2 		$8.27K Hold
100
– – ﹤0.01% 363
2024
Q1 		$8.54K Hold
100
– – ﹤0.01% 357
2023
Q4 		$8.55K Hold
100
– – ﹤0.01% 344
2023
Q3 		$8.96K Hold
100
– – ﹤0.01% 353
2023
Q2 		$8.28K Hold
100
– – ﹤0.01% 318
2023
Q1 		$8.28K Hold
100
– – ﹤0.01% 305
2022
Q4 		$8K Hold
100
– – ﹤0.01% 318
2022
Q3 		$7K Hold
100
– – ﹤0.01% 306
2022
Q2 		$7K Hold
100
– – 0.01% 156
2022
Q1 		$6K Hold
100
– – ﹤0.01% 165
2021
Q4 		$5K Hold
100
– – ﹤0.01% 175
2021
Q3 		$7K Hold
100
– – ﹤0.01% 175
2021
Q2 		$7K Buy
+100
New +$7.08K ﹤0.01% 151

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's HAE Position: Q2 2026 in Review

Clearstead Trust held its Haemonetics (HAE) position steady in Q2 2026 at 100 shares worth $7.5K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Clearstead Trust first reported a position in HAE in Q2 2021 and has held it in 21 quarters since. The position peaked at $8.96K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Clearstead Trust held 100 shares of Haemonetics worth $7.5K as of Q2 2026.
  • Clearstead Trust left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #690 holding.
  • Clearstead Trust first reported a position in Haemonetics in Q2 2021 and has held it in 21 quarters since.
  • Clearstead Trust's Haemonetics position peaked at $8.96K in Q3 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.